Investigating a new E. coli system linked to higher patient mortality
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality
This study is looking at how different genes in E. coli bacteria might influence how well patients recover from severe infections, with the hope of finding new ways to help improve treatment and care for those affected.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10873790 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetic variations in E. coli bacteria affect patient outcomes in cases of severe infections. By examining specific pathogenicity islands in E. coli, the study aims to uncover how these genetic factors contribute to increased mortality rates. The approach involves detailed laboratory work to analyze bacterial genetics and their relationship with patient health. Ultimately, the goal is to identify new treatment targets that could improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with invasive gram-negative bacterial infections, particularly those caused by E. coli.
Not a fit: Patients with infections caused by other types of bacteria or those not experiencing severe infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments that significantly improve survival rates for patients with severe E. coli infections.
How similar studies have performed: Other research has shown promise in understanding bacterial genetics and its impact on patient outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Thaden, Joshua T — Duke University
- Study coordinator: Thaden, Joshua T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.